行情

TFX

TFX

泰利福
NYSE

实时行情|Nasdaq Last Sale

331.94
+5.05
+1.54%
已收盘, 16:38 11/12 EST
开盘
327.95
昨收
326.89
最高
334.22
最低
326.95
成交量
20.61万
成交额
--
52周最高
373.90
52周最低
226.02
市值
153.62亿
市盈率(TTM)
35.37
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TFX 新闻

  • Teleflex to Showcase its Interventional Portfolio Highlighting the MANTA® Vascular Closure Device and the Langston® Dual Lumen Catheters at the PCR London Valves 2019
  • GlobeNewswire.1天前
  • Edited Transcript of TFX earnings conference call or presentation 31-Oct-19 12:00pm GMT
  • Thomson Reuters StreetEvents.2天前
  • Barclays Maintains Equal-Weight on Teleflex, Raises Price Target to $365
  • Benzinga.11/04 13:30
  • Teleflex to Present at the Stephens Nashville 2019 Investment Conference
  • GlobeNewswire.11/04 11:45

更多

所属板块

医疗设备、用品及经销
+0.68%
医疗设备和用品
+0.81%

热门股票

名称
价格
涨跌幅

TFX 简况

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company's products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products, which are offered under Hudson RCI brand. As of December 31, 2016, it manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Its all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.
展开

Webull提供Teleflex Incorporated的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。